Update on Transcatheter Device Closure of Congenital Septal Defects

Wood, Kathleen P.; Fleming, Gregory A.; Chamberlain, Reid C.

doi:10.1007/s11886-023-01925-3

Cited by 2 publications

(4 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Compared to surgical closure, transcatheter closure is reported to be less traumatic, does not require intensive care, provides faster recovery, and causes fewer complications [ 11 ]. Despite these advantages of transcatheter ASD closure, the rate of complications may increase for reasons such as inappropriate patient selection, wrong choice of procedure, and lack of experience [ 12 ].…”

Section: Discussionmentioning

confidence: 99%

Transcatheter Closure of Secundum Atrial Septal Defects in Pediatric Patients: A 15-Year Single-Center Experience

Doğan,

Levent

2024

Cureus

View full text Add to dashboard Cite

Purpose: Transcatheter closure is the first-line treatment option for hemodynamically significant secundum atrial septal defects (ASDs). This study examines our center’s experience with this procedure over the last 15 years. Materials and methods: Pediatric patients aged 0-18 years with secundum ASDs who were planned for transcatheter closure in our clinic between January 2007 and January 2023 were retrospectively evaluated. Results: Transcatheter secundum ASD closure was planned for a total of 334 patients during the study period: 191 girls (57.2%) and 143 boys (42.8%). Their mean age was 8.08±3.9 years, and their mean weight was 30±15.6 kg. Defect diameter measured transesophageally ranged from 5 to 35 mm, with a mean of 12.56±4.02 mm. Transesophageal echocardiographic examination revealed a single secundum ASD in 319 patients (95.5%) and multiple secundum ASDs in 15 patients (4.5%). In 11 patients (3.3%), the procedure was terminated before initiating transcatheter ASD closure because of insufficient vena cava rims or a very large or multi-fenestrated defect. The 323 patients (96.7%) who underwent transcatheter ASD closure had a mean pulmonary artery pressure of 15.1±4.0 mmHg and a mean Qp/Qs ratio of 1.97±0.56. The procedure failed in four patients (1.3%) because of device embolization (n=2) or the inability to properly position the device (n=2). Major complications other than device embolization observed during or after transcatheter closure included anesthetic-induced respiratory depression (n=1) and total atelectasis of the lung (n=1). No new major complications were detected during the patients’ long-term follow-up. Conclusion: With appropriate patient and device selection, transcatheter closure is a safe and effective treatment for secundum ASD and should be the first treatment of choice.

show abstract

Section: Discussionmentioning

confidence: 99%

Transcatheter Closure of Secundum Atrial Septal Defects in Pediatric Patients: A 15-Year Single-Center Experience

Doğan,

Levent

2024

Cureus

View full text Add to dashboard Cite

show abstract

“…In recent years, the use of percutaneously implanted occluding devices for the closure of OS ASD has become an increasingly popular alternative to surgical closure for patients with suitable anatomy, due to its minimally invasive nature and reduced rate of early complications and length of stay [ 2 , 3 ]. However, these devices can be associated with late complications, including residual shunt, device erosion, device migration, late device fracture, thrombus formation, infective endocarditis, and atrial arrhythmias [ 3 , 4 , 5 , 6 , 8 ].…”

Section: Discussionmentioning

confidence: 99%

“…Early complications following ASD occlusion can occur during the procedure or in the immediate post-procedural period and include device malposition, embolization, air embolism, cardiac perforation, and arrhythmia [ 3 , 4 , 5 , 6 , 7 ].…”

Section: Introductionmentioning

confidence: 99%

“…Several late complications have been reported in the literature, including residual shunt, device erosion, device migration, late device fracture, thrombus formation, infective endocarditis, and atrial arrhythmias [ 3 , 4 , 5 , 6 , 8 ]. Device erosion can occur months to years after the device is implanted and can result in fistula formation, pericardial effusion, tamponade, and even death [ 9 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Unveiling an Unusual Cause of Cardiac Tamponade

Conde,

Salomé,

Sousa

et al. 2023

Cureus

View full text Add to dashboard Cite

This case presents a 48-year-old woman initially diagnosed with an ostium secundum atrial septal defect (ASD) at the age of 36. Twelve years post-intervention, she presented to the emergency department with cardiac tamponade. This case highlights the importance of maintaining prolonged follow-up for individuals undergoing percutaneous ASD closure, given the possibility of potentially fatal late complications of ASD occlusion devices.

show abstract

Update on Transcatheter Device Closure of Congenital Septal Defects

Cited by 2 publications

References 53 publications

Transcatheter Closure of Secundum Atrial Septal Defects in Pediatric Patients: A 15-Year Single-Center Experience

Transcatheter Closure of Secundum Atrial Septal Defects in Pediatric Patients: A 15-Year Single-Center Experience

Unveiling an Unusual Cause of Cardiac Tamponade

Contact Info

Product

Resources

About